29 reports

  • 8.5.1 UNMET NEED
  • 7.1.6 ONZETRA XSAIL (SUMATRIPTAN SUCCINATE)

SUBJECTS REPORTED PAIN RELIEF IN LESS THAN ## MINUTES, WITH ##% OF SUBJECTS REPORTING PAIN RELIEF WITHIN ONE HOUR OF ADMINISTRATION OF A SINGLE ##MG SUBCUTANEOUS DOSE OF IMITREX INJECTION.

  • Pain Relief
  • United States
  • Allergan plc
  • Amgen Inc.
  • Pfizer Inc.

(USA) ##.

  • Pain Relief
  • United States
  • Demand
  • Market Competition
  • Market Shares

(USA) ##.

  • Analgesic
  • Opioid
  • Pain Relief
  • United States
  • Market Shares
  • Sales of Top Anti-Migraine Products in 2017
  • ANTI-MIGRAINE DRUGS

The company' s Respiratory and Personal Care include Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp and ChapStick.

  • Pain Relief
  • United States
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

IN JULY 2014, GSK RECALLED PANADOL ADVANCE ## CT PAIN RELIEF PRODUCTS FROM PUERTO RICO CONSUMERS, AS IT LACKED A CHILD RESISTANT FEATURE AND IS NOT LABELED AS A PRODUCT " FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN".

  • Pain Relief
  • United States
  • AstraZeneca PLC
  • Mylan Inc.
  • Pfizer Inc.
  • Neurophyxia B.V. is an innovative clinical stage drug development company, focusing on disorders affecting the newborn child announces the start of formal preclinical development of 2-IB (manufacturing and safety studies).
  • OCT 31, 2010: NEURAXON REPORTS NXN-188 PHASE II DATA DEMONSTRATES EFFICACY IN ACUTE MIGRAINE

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H1 2018 Summary Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl...

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • NeurAxon, Inc.
  • 9.3 GLAXOSMITHKLINE (GSK)
  • 3.4 MIGRAINE SPECIFIC DRUGS

However, rizatriptan may provide better pain relief than many of the other triptans.

  • Pain Relief
  • United States
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • SENSUS RLS - USE OF WEARABLE PAIN RELIEF TECHNOLOGY IN RESTLESS LEG SYNDROME
  • MAY 08, 2017: NEUROMETRIX REPORTS SUBSTANTIAL EXPANSION OF INTERNATIONAL INTELLECTUAL PROPERTY ASSETS FOR QUELL WEARABLE PAIN RELIEF TECHNOLOGY

Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS...

  • Pain Relief
  • United States
  • Company Financials
  • Product Initiative
  • NeuroMetrix, Inc.

Worth to note is the rapidly installed and long lasting pain relief achieved by the MCS-Injection therapy.

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • Analgesics and Other Pain Relievers

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Pain Relief
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION
  • PAIN RELIEF DEVICE - PRODUCT STATUS

Pain Management - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2017" provides an overview of Pain Management currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company
  • CAPSAICIN - DRUG PROFILE

Worth to note is the rapidly installed and long lasting pain relief achieved by the MCS-Injection therapy.

  • Arthritis
  • Pain Relief
  • Therapy
  • United States
  • Flex Pharma, Inc.
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Product Development Milestones
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Companies Involved in Therapeutics Development

Pain relief was sustained throughout ## hours.

  • OTC
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • 4.3 Challenges

Example, one may experience headache pain as a vise-like band circling the head, while others fell a throbbing pain on one side of head.

  • Pain Relief
  • North America
  • United States
  • Forecast
  • Amgen Inc.
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Product Development Milestones
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Companies Involved in Therapeutics Development

Excessive use of acute pain-relief medication is common among people who suffer from migraine.

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • Cluster Headache Syndrome - Companies Involved in Therapeutics Development
  • CLUSTER HEADACHE SYNDROME - PIPELINE BY ELI LILLY AND COMPANY, H2 2017

Cluster headache is pain that occurs along one side of the head.

  • OTC
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • Jun 17, 2016: Zosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine
  • Jan 05, 2017: Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial

Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings, Inc, is a emerging CNS company that provides pharmaceutical products.The company offers development of transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. Its lead product...

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation
  • NOV 09, 2016: COLUCID PHARMACEUTICALS ANNOUNCES 2016 THIRD QUARTER RESULTS AND CORPORATE HIGHLIGHTS

Both the ## mg and ## mg doses of lasmiditan were also more efficacious than placebo on headache pain relief at the two-hour time point (p ##. ##), as a rescue medication on headache pain freedom at the two-hour time point (p ##. ## and p ##. ##), in reducing migraine relat

  • Pain Relief
  • Pharmaceutical
  • United States
  • Supply
  • CoLucid Pharmaceuticals, Inc.
  • Product Development Milestones

These symptoms A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Cluster Headache Syndrome - Companies Involved in Therapeutics Development
  • CLUSTER HEADACHE SYNDROME - PIPELINE BY CROSSJECT SA, H1 2018

Cluster headache is pain that occurs along one side of the head.

  • OTC
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative

BACTINE IS AN OVER-THE-COUNTER HEALTHCARE PRODUCT, BRINGING BOTH PAIN RELIEF FOR FIRST AID INJURIES AND AN ANTISEPTIC THAT KILL GERMS.

  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • United States
  • Bayer AG
  • MTR-106 - DRUG PROFILE
  • DRUG TO AGONIZE MOR1 FOR MIGRAINE - DRUG PROFILE

Migraine - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H1 2018, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated...

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • KETOPROFEN - DRUG PROFILE
  • UBROGEPANT - DRUG PROFILE

A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Other Developmental Activities
  • dihydroergotamine mesylate

Additional endpoints showed that levadex provided rapid and sustained pain relief for up to ## hours after dosing.

  • Ophthalmology
  • Pain Relief
  • United States
  • M&A
  • Allergan plc

Pyralvex is used for the symptomatic relief of pain associated with recurrent mouth ulcers and denture irritation.

  • Cardiology
  • Pain Relief
  • Pharmaceutical
  • United States
  • Valeant Pharmaceuticals International, Inc.

Pyralvex is used for the symptomatic relief of pain associated with recurrent mouth ulcers and denture irritation.

  • Cardiology
  • Pain Relief
  • Pharmaceutical
  • United States
  • Valeant Pharmaceuticals International, Inc.

It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics.

  • Immunology
  • Pain Relief
  • United States
  • M&A
  • Perrigo Company
  • FEATURED NEWS & PRESS RELEASES

Better tissue penetration should reduce inflammatory symptoms, which are key to preventing post-surgical side effects, in addition to providing longer lasting pain relief to patients. "

  • Eye Disease
  • Pain Relief
  • United States
  • Product Initiative
  • InSite Vision Incorporated

The secondary outcome measures were modified brief pain inventory short form (mbpi-sf) intensity, To evaluate pain relief using the pain relief item of the mbpi-sf, To evaluate the pain-related quality of life using the pain interference

  • Pain Relief
  • United States
  • Company Operations
  • Product Initiative
  • Mallinckrodt plc